Abstracts Archive - Page 2468 of 2607 - ACR Meeting Abstracts

Abstract Number: 2059 • 2012 ACR/ARHP Annual Meeting
The Efficacy of Clinical Guidelines in Promoting Co-Prescription of Bone Protection with Glucocorticoids Among Hospital Doctors Treating Inpatients
Leonard C. Harty¹, James Clare², Dylan Finnerty², Susan Van Der Kamp², Fionnuala Kennedy³, Malachi McKenna⁴ and Oliver M. FitzGerald¹, ¹Rheumatology, Dublin Academic Medical Centre, St. Vincent's University Hospital, Dublin, Ireland, ²Department of Rheumatology, St. Vincent's University Hospital, Dublin, Ireland, ³Pharmacy Department, St. Vincent's University Hospital, Dublin, Ireland, ⁴Department of Endocrinology & Metabolic Bone Disease, St. Vincent's University Hospital, Dublin, Ireland
Background/Purpose: Therapeutic glucocorticoids (GC) rapidly decrease bone mineral density, inducing a remodelling imbalance by promoting osteoclast differentiation and activation and by inhibiting oscteocytes. Current guidelines…
Abstract Number: 2060 • 2012 ACR/ARHP Annual Meeting
Using the Electronic Medical Record to Increase Rates of Physician Assessment of Lipids in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: A Quality Improvement Initiative
Astrud Lorraine Leyva¹, Laura L. Tarter¹, Elizabeth Blair Solow² and David R. Karp³, ¹Division of Rheumatic Diseases, UT Southwestern Medical Center, Dallas, TX, ²Rheumatology, UT Southwestern Medical Center, Dallas, TX, ³Rheumatic Diseases Division, UT Southwestern Medical Center, Dallas, TX
Background/Purpose: Cardiovascular disease (CVD) is a major cause of morbidity and mortality in rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). Guidelines for the management…
Abstract Number: 2020 • 2012 ACR/ARHP Annual Meeting
Assessment of Procedure Safety and Cannula Position in Temporomandibular Joint Puncture Evaluated by Cone Beam Computerized Tomography
Thomas K. Pedersen¹, Kasper D. Kristensen¹, Per Alstergren², Peter Stoustrup³, Annelise Küseler¹ and Troels Herlin⁴, ¹Department of Orthodontics, University of Aarhus, Aarhus C, Denmark, ²Department of Orofacial Pain and Jaw Function Faculty of Odontology, Malmö University, Malmö, Sweden, ³Section of Orthodontics, University of Aarhus, Aarhus C, Denmark, ⁴Pediatric Rheumatology Clinic, Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark
Background/Purpose: Temporomandibular joint (TMJ) arthritis frequently occurs in juvenile idiopathic arthritis (JIA). Only sparse information is available concerning the inflammatory activity and the underlying biology…
Abstract Number: 2021 • 2012 ACR/ARHP Annual Meeting
The Schedule of Administration of Canakinumab in Cryopyrin Associated Periodic Syndrome Is Driven by the Phenotype Severity Rather Than the Age
Roberta Caorsi¹, Loredana Lepore², Francesco Zulian³, Maria Alessio⁴, Achille Stabile⁵, Antonella Insalaco⁶, Martina Finetti¹, Antonella Battagliese⁴, Giorgia Martini⁷, Chiara Bibalo⁸, Alberto Martini⁹ and Marco Gattorno¹, ¹Second Division of Paediatrics, G. Gaslini Institute, Genova, Italy, ²Istituto Burlo Garofolo, Trieste, Italy, ³Department of Pediatrics, University of Padua, Padova, Italy, ⁴Department of Pediatrics,, Federico II Hospital, Napoli, Italy, ⁵DipartimentoPediatria, Policlinico Gemelli, Roma, Italy, ⁶Department of Pediatric Rheumatology, Ospedale Pediatrico Bambino Gesù, Roma, Italy, ⁷Department of Pediatrics,, University of Padua, Padua, Italy, ⁸Pediatrics-Univ of Trieste, Ospedale-Infantile Trieste, Trieste, Italy, ⁹Pediatric Rheumatology Collaborative Study Group [PRSCG], Cincinnati, OH
Background/Purpose: to identify the optimal regimen for the treatment with Canakinumab in CAPS patients and, in patients receiving both Anakinra and Canakinumab during their disease…
Abstract Number: 2022 • 2012 ACR/ARHP Annual Meeting
Individual Disease Burden in Children and Adolescents with Chronic Musculoskeletal Pain – Multilevel-Analysis of a Nationwide Prospective Longitudinal Observation Study
Kerstin Gerhold¹, Rebecca Muckelbauer², Jacqueline Müller-Nordhorn², Angelika Thon³, Thomas Müller⁴, Gerd Ganser⁵, Martina Niewerth⁶ and Kirsten Minden⁷, ¹Programme Area Epidemiology, German Rheumatism Research Center, a Leipniz Institute, Berlin, Germany, ²Berlin School of Public Health, Charité - Universitätsmedizin Berlin, Berlin, Germany, ³Kinderklinik der Medizinischen Hochschule Hannover, Hannover, Germany, ⁴Universitätsklinikum Halle (Saale), Halle (Saale), Germany, ⁵Pediatric Rheumatology, Sankt Josef Stift, Sendenhorst, Germany, ⁶Epidemiology unit, German Rheumatism Research Center, Berlin, Germany, ⁷Programme Area Epidemiology, German Rheumatism Research Center, a Leibniz Institute, Berlin, Germany
Background/Purpose: Chronic musculoskeletal pain was described to be a frequent complaint in children and adolescents with assumed relevant impairment of health-related quality of life (HRQoL)…
Abstract Number: 2023 • 2012 ACR/ARHP Annual Meeting
Should Joint Ultrasound Contribute to Therapeutic Decisions in Juvenile Idiopathic Arthritis?
Marie Halbwachs¹, Geraldine Durand², Caroline Robin¹, Catherine Gambert Abdel Rahman¹, Pierre Ingrand³ and Elisabeth Solau-Gervais², ¹Paediatric, University Hospital, Poitiers, France, ²Rheumatology, University Hospital, Poitiers, France, ³Inserm, CIC-P 802, University Hospital, Poitiers, France
Background/Purpose: Over several years, numerous studies have been published on the interest of joint ultrasound in juvenile idiopathic arthritis. Several authors have demonstrated that ultrasonography…
Abstract Number: 2024 • 2012 ACR/ARHP Annual Meeting
Articular Symptoms in Cryopyrin-Associated Periodic Syndrome: Retrospective French Study
Laetitia Houx¹, Pierre Quartier², Isabelle Kone-Paut³, Xavier Guennoc⁴, Pascal Pillet⁵, Thierry Lequerre⁶, Irene Lemelle⁷, Mohamed Hamidou⁸, Gilles Grateau⁹, Eric Hachulla¹⁰, Jean-Marie Berthelot¹¹, Benedicte Neven¹², Christophe Richez¹³, Anne Pagnier¹⁴, Veronique Hentgen¹⁵ and Valerie Devauchelle-Pensec¹⁶, ¹Physical Medical Rehabilitation, Brest, France, ²Necker-Enfants Malades Hospital,, Paris, France, ³Pediatrics, Hospital Kremlin Bicêre, Kremlin-Bicêtre, France, ⁴Rheumatology, Hopital de Saint Brieuc, France, ⁵Paediatry, CHU, Bordeaux, France, ⁶Rheumatology, Rouen, France, ⁷Paediatry, CHU, Nancy, France, ⁸Internal Medicine Department, Nantes University Hospital, Nantes, France, ⁹Service De Médecine Interne, Hopital Tenon, Paris, France, ¹⁰Department of Internal Medicine, Claude Huriez University Hospital, Lille, France, ¹¹Rheumatology Unit, Nantes University Hospital, Nantes, France, ¹²Inserm U768, Paris, France, ¹³Rheumatology, Hôpital Pellegrin and Université Victor Segalen Bordeaux, Bordeaux, France, ¹⁴Service de pediatrie, Grenoble, France, ¹⁵Versailles Hospital, Le Chesnay Cedex, France, ¹⁶Department of rheumatology and unit of immunology (EA2216), Brest Occidentale university, Brest, France
Background/Purpose: The cryopyrin-associated periodic syndrome (CAPS) is a rare inherited inflammatory disease associated with a mutation in the NLRP3 gene. Articular symptoms are often described…
Abstract Number: 2025 • 2012 ACR/ARHP Annual Meeting
Clinical Characteristics and Therapy Response in a Large Single-Centre Cohort of Patients with Periodic Fever with Aphtous Stomatitis, Pharyngitis and Cervical Adenitis Syndrome
Francesca Ricci¹, Antonella Meini¹, Lucio Verdoni², Laura Dotta¹, Marta Bolis², Marco Berlucchi³, Gianfranco Savoldi⁴ and Marco Cattalini², ¹Pediatric Clinic, University of Brescia and Spedali Civili di Brescia, Pediatric Immunology and Rheumatology Unit, Brescia, Italy, ²Pediatric Clinic, Spedali Civili di Brescia and University of Brescia, Pediatric Immunology and Rheumatology Unit, Brescia, Italy, ³Spedali Civili di Brescia, Department of Pediatric Otorhinolaryngology, Brescia, Italy, ⁴Spedali Civili di Brescia, Angelo Nocivelli Institute of Molecular Medicine, Brescia, Italy
Background/Purpose: PFAPA (Period Fever with Aphtous stomatitis, Pharyngitis and cervical Adenitis), is a periodic syndrome described for the first time in 1987 by Marshall et…
Abstract Number: 2026 • 2012 ACR/ARHP Annual Meeting
High Prevalence of Cervical Spine and Temporomandibular Joint Involvement in Patients with Juvenile Idiopathic Arthritis
Nikolay Tzaribachev¹, Catrin Tzaribachev¹ and Bernd Koos², ¹Pediatric Rheumatology, Center for Rheumatic Diseases, Bad Bramstedt, Germany, ²Clinic of Orthodontics, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany
Background/Purpose: Detection of involvement of temporomandibular joints (TMJ), which are frequently affected by juvenile idiopathic arthritis (JIA), is only possible on Gadolinium enhanced MRI…
Abstract Number: 2027 • 2012 ACR/ARHP Annual Meeting
Chronic Nonbacterial Osteomyelitis of the Mandible in Children: a Tertiary Center Experience
Daniela S. Ardelean¹ and Ronald Laxer², ¹Pediatric Rheumatology, Hospital for Sick Children, Toronto, ON, Canada, ²Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada
Background/Purpose: Chronic nonbacterial osteomyelitis (CNO) of the mandible is a rare osseous autoinflammatory disease. Diagnosis is based on characteristic clinical, laboratory and imaging features. Our…
Abstract Number: 2028 • 2012 ACR/ARHP Annual Meeting
Medication Adherence and Quality of Life in Children with Rheumatic Disease
Stacey E. Tarvin¹, Lisa M. Macharoni², Christine M. Raches³ and Nicole M. Taylor², ¹Pediatric Rheumatology, Riley Hospital for Children, Indianapolis, IN, ²School of Psychological Sciences, University of Indianapolis, Indianapolis, IN, ³Riley Child Development Center, Riley Hospital for Children, Indianapolis, IN
Background/Purpose: Children with rheumatic diseases are often prescribed complex medication regimens. Medication side-effects may have a negative impact on physical appearance and subsequently impact adherence. …
Abstract Number: 2029 • 2012 ACR/ARHP Annual Meeting
Reliability of Scoring a Disease Damage Measure for Juvenile Localized Scleroderma
Kathryn S. Torok¹, Suzanne C. Li², Christina Kelsey³, Mara L Becker⁴, Fatma Dedeoglu⁵, Robert C. Fuhlbrigge⁶, Gloria Higgins⁷, Sandy D. Hong⁸, Maria F. Ibarra⁹, Ronald Laxer¹⁰, Thomas G. Mason II¹¹, Marilynn G. Punaro¹², Elena Pope¹³, C. Egla Rabinovich¹⁴ and Katie G. Stewart¹², ¹Pediatric Rheumatology, Scleroderma Center of Pittsburgh, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, ²Pediatrics, Joseph M Sanzari Children's Hospital, Hackensack University Medical Center, Hackensack, NJ, ³Pediatric Rheumatology, Univ of Pittsburgh Med Ctr, Pittsburgh, PA, ⁴Clinical Pharmacology and Rheumatology, Children's Mercy Hospital, Kansas City, MO, ⁵Division of Immunology, Boston Children's Hospital, Boston, MA, ⁶Pediatric Rheumatology, Childrens Hospital, Boston, MA, ⁷Pediatric Rheumatology NATIONWIDE CHILDRENS HOSPITAL, PRCSG-Cincinnati Children's Hospital Medical Center, Columbus, OH, ⁸Pediatrics-Rheumatology, U of Iowa Children's Hosp, Iowa City, IA, ⁹Pediatric Rheumatolgy, Children's Mercy Hospital, Kansas City, MO, ¹⁰Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, ¹¹Rheumatology, Mayo Clinic Rochester, Rochester, MN, ¹²Pediatric Rheumatology, Texas Scottish Rite Hospital, Dallas, TX, ¹³Dermatology, The Hospital for Sick Children, Toronto, ON, Canada, ¹⁴Pediatric Rheumatology, Duke University Medical Center, Durham, NC
Background/Purpose: . In order to more accurately capture disease activity and damage in juvenile Localized Scleroderma (jLS) and to develop an accepted outcome measure for…
Abstract Number: 2030 • 2012 ACR/ARHP Annual Meeting
A Multi-Modal Amplified Musculoskeletal Pain Treatment Program: Associations of Previous Pharmacotherapy with Subsequent Outcomes
Cara M. Hoffart¹, Pamela Weiss², David D. Sherry³, Chris Feudtner⁴ and Margaret Stineman⁵, ¹The Children's Hospital of Philadelphia, Philadelphia, PA, ²Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Philadelphia, PA, ³Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, ⁴Division of General Pediatrics, Children's Hospital of Philadelphia; University of Pennsylvania Center for Clinical Epidemiology and Biostatistics, Philadelphia, PA, ⁵The University of Pennsylvania, Philadelphia, PA
Background/Purpose: Management of Amplified Musculoskeletal Pain (AMP) in children (i.e. juvenile primary fibromyalgia, complex regional pain syndrome, neuropathic pain, central sensitization) remains controversial. Common practice…
Abstract Number: 2031 • 2012 ACR/ARHP Annual Meeting
Safety and Efficacy of Anakinra in Patients with Deficiency of Interleukin-1 Receptor Antagonist
Gina A. Montealegre¹, Adriana Almeida de Jesus², Dawn C. Chapelle³, Paul Dancey⁴, Joost Frenkel⁵, Annet van Royen-Kerkhoff⁶, Ronit Herzog⁷, Giovanna Ciocca⁸, Rafael F. Rivas-Chacon⁸, Ann M. Reed⁹, Nicole Plass³, Ivona Aksentijevich¹⁰, Polly J. Ferguson¹¹, Suvimol C. Hill¹², Edward Cowen¹³ and Raphaela T. Goldbach-Mansky³, ¹NIAMS, Bethesda, MD, ²Translational Autoinflammatory Disease Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, MD, ³Translational Autoinflammatory Diseases Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, MD, ⁴Health Science Centre, Memorial University of Newfoundland, St Johns, Canada, ⁵Wilhelmina Childrens Hospital, University of Utrecht, Utrecht, Netherlands, ⁶University of Utrecht, Utrecht, Netherlands, ⁷Cornell University, New York, NY, ⁸Miami Children's Hospital, Miami, FL, ⁹Rheumatology, Mayo Clinic, Rochester, MN, ¹⁰Inflammatory Disease Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, ¹¹Dept of Pediatrics--Rheum, University of Iowa Carver College of Medicine, Iowa City, IA, ¹²Radiology and Imaging Sciences, NIH Clinical Center, Bethesda, MD, ¹³Dermatology Consultation Servce, National Cancer Institute, National Institutes of Health, Bethesda, MD
Background/Purpose: Deficiency of interleukin-1 receptor antagonist (DIRA) is a neonatal-onset autoinflammatory syndrome caused by mutations in IL1RN gene and clinically characterized by a perinatal onset…
Abstract Number: 2032 • 2012 ACR/ARHP Annual Meeting
Results From a Multicentre International Registry of Familial Mediterranean Fever: Impact of Genetic and Environment Factors On the Expression of a Monogenic Disease in Children
Seza Ozen¹, Erkan Demirkaya², Gayane Amaryan³, Isabelle Koné-Paut³, Adem Polat³, Turker Turker³, Patricia Woo⁴, Yosef Uziel⁵, Consuelo Modesto³, Martina Finetti³, Pierre Quartier⁶, Efimia Papadopoulou-Alataki³, Sulaiman Al-Mayouf³, Giovanna Fabio³, Romina Gallizzi⁷, Luca Cantarini⁸, Joost Frenkel⁹, Susan Nielsen¹⁰, Michael Hofer³, Antonella Insalaco³, Huri Ozdogan³, Nicolino Ruperto³ and Marco Gattorno³, ¹Hacettepe University, Ankara, Turkey, ²Gulhane Military Medical Faculty, Ankara, Turkey, ³Paediatric Rheumatology International Trials Organization (PRINTO), Istituto Giannina Gaslini, Genova, Italy, ⁴University College London, London, United Kingdom, ⁵Pediatric Rheumatology, Meir medical center, Kfar Saba, Israel, ⁶Pediatric Rheumatology, IMAGINE Institute, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris, Université Paris-Descartes, Paris, France, ⁷University of Messina, Messina, Italy, ⁸University of Siena, Siena, Italy, ⁹University Medical Center Utrecht, Utrecht, Netherlands, ¹⁰Istituto Giannina Gaslini, Genoa, Italy
Background/Purpose: Familial Mediterranean Fever (FMF) is an autoinflammatory disease caused by mutations in a single gene, the MEFV gene. The disease is very frequent among…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].